Village Super Market
VLGEA
43.83
+0.01
+0.03%
Village Super Market
US · VLGEA
#3573 by market cap
43.83
+0.01
+0.03%
Live - 5344 symbols - heartbeat 44s ago
· 2026-10-08 10:07
Pre-market
43.82
0.00%
After-hours
43.82
0.00%
- Market cap
- 649.12M
- P/E (TTM)i
- 11.94
- P/Bi
- 1.26
- EPSi
- 3.81
- Div yieldi
- 2.28%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on VLGEA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.93, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.76% YoY
Margins
- Gross margin
- 28.57%
- Operating margin
- 3.17%
- Net margin
- 2.43%
Key ratios & quality
- Enterprise valuei
- 619.98M
- PEG ratioi
- 0.43
- Altman Z-Scorei
- 3.93
PEG uses trailing P/E against the 3-year net income growth rate (28.09%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.62B | 1.64B | 1.80B | 2.03B | 2.06B | 2.17B | 2.24B | 2.32B |
| Gross profit | 443.03M | 456.72M | 506.48M | 565.04M | 579.67M | 616.45M | 641.98M | 662.97M |
| Selling & admin expenses | 384.58M | 394.75M | 444.83M | 498.79M | 507.60M | 516.90M | 544.35M | 555.04M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 33.45M | 34.68M | 30.28M | 32.06M | 38.95M | 65.55M | 64.18M | 73.53M |
| Pretax profit | 32.84M | 35.52M | 31.73M | 28.85M | 39.06M | 72.73M | 72.72M | 81.82M |
| Tax | 7.76M | 9.98M | 6.79M | 8.86M | 12.23M | 23.01M | 22.26M | 25.44M |
| Net profit | 25.08M | 25.54M | 24.94M | 19.99M | 26.83M | 49.72M | 50.46M | 56.38M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 |
| Diluted EPS | 1.74 | 1.77 | 1.72 | 1.37 | 1.84 | 3.38 | 3.40 | 3.81 |
| Line item | 2025-01 | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 |
|---|---|---|---|---|---|---|
| Revenue | 599.65M | 563.67M | 599.67M | 582.59M | 640.96M | 572.59M |
| Gross profit | 170.01M | 162.18M | 168.90M | 164.95M | 179.88M | 160.81M |
| Selling & admin expenses | 139.25M | 139.68M | 138.58M | 141.45M | 147.89M | 143.77M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 22.15M | 13.73M | 21.68M | 15.10M | 23.46M | 8.41M |
| Pretax profit | 24.52M | 16.08M | 22.61M | 17.51M | 25.79M | 10.70M |
| Tax | 7.63M | 4.92M | 7.09M | 5.51M | 7.92M | 1.74M |
| Net profit | 16.90M | 11.16M | 15.52M | 12.00M | 17.87M | 8.96M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 1.14 | 0.75 | 1.05 | 0.81 | 1.21 | 0.61 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 190.90M | 168.78M | 197.32M | 196.32M | 237.97M | 246.69M | 199.70M | 205.11M |
| Cash & ST investments | 96.11M | 101.12M | 111.68M | 116.31M | 134.83M | 140.91M | 117.26M | 110.70M |
| Inventory | 39.41M | 38.50M | 42.14M | 42.63M | 44.19M | 44.52M | 46.74M | 51.42M |
| Total assets | 481.59M | 502.29M | 915.55M | 889.00M | 924.45M | 967.71M | 981.66M | 1.00B |
| Total current liabilities | 101.70M | 112.47M | 162.80M | 152.29M | 158.17M | 178.97M | 174.22M | 181.27M |
| Short-term debt | 878.00K | 1.07M | 26.31M | 29.77M | 29.55M | 31.16M | 32.39M | 32.53M |
| Long-term debt | 6.42M | 6.97M | 75.08M | 69.62M | 68.23M | 74.11M | 63.68M | 49.03M |
| Total liabilities | 178,445,000.00 | 183,617,000.00 | 583,226,000.00 | 547,531,000.00 | 552,339,000.00 | 557,540,000.00 | 534,105,000.00 | 511,747,000.00 |
| Total equity | 303.15M | 318.67M | 332.32M | 341.47M | 372.11M | 410.17M | 447.56M | 491.96M |
| Retained earnings | 258.10M | 270.75M | 286.24M | 293.19M | 306.97M | 343.50M | 380.62M | 423.69M |
| Line item | 2025-01 | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 |
|---|---|---|---|---|---|---|
| Total current assets | 210.27M | 195.03M | 205.11M | 212.91M | 234.61M | 212.18M |
| Cash & ST investments | 133.93M | 115.36M | 110.70M | 117.69M | 160.11M | 128.68M |
| Inventory | 49.90M | 51.18M | 51.42M | 54.15M | 45.18M | 51.16M |
| Total assets | 1.00B | 995.57M | 1.00B | 1.00B | 1.03B | 1.01B |
| Total current liabilities | 185.45M | 183.88M | 181.27M | 181.39M | 191.47M | 182.10M |
| Short-term debt | 32.37M | 32.72M | 32.53M | 32.54M | 32.68M | 32.96M |
| Long-term debt | 53.78M | 51.24M | 49.03M | 46.56M | 49.91M | 47.45M |
| Total liabilities | 530,154,000.00 | 515,893,000.00 | 511,747,000.00 | 503,189,000.00 | 510,579,000.00 | 493,541,000.00 |
| Total equity | 471.97M | 479.68M | 491.96M | 501.09M | 516.67M | 514.90M |
| Retained earnings | 403.66M | 411.50M | 423.69M | 432.37M | 446.91M | 452.53M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 58.88M | 55.79M | 83.95M | 52.69M | 79.63M | 104.51M | 80.85M | 93.22M |
| Depreciation & amortization | 25.00M | 27.29M | 31.70M | 35.70M | 34.71M | 35.71M | 35.46M | 36.65M |
| Free cash flow | 23.42M | 27.80M | 29.45M | 27.46M | 36.36M | 58.11M | 17.74M | 34.46M |
| Dividends paid | -12.88M | -12.89M | -12.97M | -13.05M | -13.04M | -13.19M | -13.34M | -13.31M |
| Stock buybacks / issuance | -632.00K | -1.07M | -4.39M | 0 | -649.00K | -3.74M | -2.21M | 0 |
| Ending cash balance | 96.11M | 101.12M | 111.68M | 116.31M | 134.83M | 140.91M | 117.26M | 110.70M |
| Line item | 2025-01 | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 |
|---|---|---|---|---|---|---|
| Operating cash flow | 40.78M | 10.64M | 21.63M | 19.66M | 59.12M | -245.00K |
| Depreciation & amortization | 9.19M | 9.38M | 9.13M | 8.91M | 9.04M | 9.17M |
| Free cash flow | 24.93M | -10.52M | 11.57M | 10.71M | 50.36M | -16.29M |
| Dividends paid | -3.33M | -3.33M | -3.33M | -3.33M | -3.33M | -3.34M |
| Stock buybacks / issuance | -- | -- | 0 | -- | -- | -- |
| Ending cash balance | 133.93M | 115.36M | 110.70M | 117.69M | 161.21M | 128.68M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 8.26 | 8.00 | 7.44 | 5.93 | 5.69 | 12.71 | 11.77 | 12.00 |
| ROA %i | 5.20 | 5.06 | 3.42 | 2.22 | 2.24 | 5.26 | 5.18 | 5.68 |
| ROIC %i | 7.28 | 6.74 | 4.11 | 2.70 | 2.67 | 5.68 | 5.31 | 6.01 |
| 5-year avg ROE %i | 8.00 | 9.19 | 8.26 | 7.28 | 7.19 | 8.08 | 8.83 | 9.70 |
| EBIT margin %i | 2.31 | 2.43 | 1.90 | 1.62 | 2.08 | 3.55 | 3.44 | 3.69 |
| FCF / sales %i | 1.45 | 1.69 | 1.63 | 1.35 | 1.76 | 2.68 | 0.79 | 1.48 |
| Current ratioi | 1.88 | 1.50 | 1.21 | 1.29 | 1.50 | 1.38 | 1.15 | 1.13 |
| Quick ratioi | 1.30 | 1.01 | 0.83 | 0.88 | 1.11 | 1.03 | 0.78 | 0.72 |
| Debt / assetsi | 10.19 | 9.71 | 46.15 | 44.98 | 43.66 | 40.57 | 37.86 | 33.98 |
| LT debt / equityi | 15.90 | 14.98 | 119.22 | 108.38 | 100.52 | 88.12 | 75.81 | 62.70 |
| Interest coveragei | 8.36 | 9.01 | 13.15 | 8.32 | 11.00 | 18.23 | 18.59 | 22.81 |
| Revenue CAGR (3Y) %i | 0.65 | 0.18 | 3.99 | 7.93 | 7.84 | 6.28 | 3.28 | 4.03 |
| Net income CAGR (3Y) %i | -6.44 | 0.65 | 2.85 | -7.28 | 1.66 | 25.86 | 36.15 | 28.09 |
| FCF CAGR (3Y) %i | -- | -14.28 | 16.92 | 5.45 | 9.36 | 25.42 | -13.56 | -1.77 |
| Line item | 2025-01 | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 |
|---|---|---|---|---|---|---|
| ROE %i | 11.85 | 12.04 | 12.00 | 11.69 | 11.45 | 11.07 |
| ROA %i | 5.41 | 5.61 | 5.68 | 5.62 | 5.58 | 5.49 |
| ROIC %i | 5.65 | 5.89 | 6.01 | 5.98 | 5.97 | 5.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.58 | 3.69 | 3.69 | 3.60 | 3.58 | 3.34 |
| FCF / sales %i | 1.63 | 1.59 | 1.48 | 1.56 | 2.60 | 2.35 |
| Current ratioi | 1.13 | 1.06 | 1.13 | 1.17 | 1.23 | 1.17 |
| Quick ratioi | 0.75 | 0.68 | 0.72 | 0.77 | 0.87 | 0.77 |
| Debt / assetsi | 35.79 | 34.93 | 33.98 | 33.09 | 32.04 | 31.76 |
| LT debt / equityi | 69.12 | 65.67 | 62.70 | 59.82 | 57.38 | 55.80 |
| Interest coveragei | 20.46 | 21.88 | 22.81 | 23.28 | 24.51 | 23.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Center Store is the largest reported line at 58.48% of revenue, across 4 reported segments.
- Fresh follows at 36.62%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Center Store58.48%
Fresh36.62%
Pharmacy4.29%
Other0.61%
Quote time 2026-10-08 10:07:42 · For reference only, not investment advice and not tailored to your situation.